Furthermore, treatment with RA suppressed invasion and osteosarcomas through the modulation of NF-κB signaling pathways by targeting IκBα phosphorylation to attenuate transcriptional activity of the NF-κB signaling pathway. Here, NFKB1 is linked to osteosarcoma.